FDA Just Fast-Tracked a Vaccine for Alzheimer's

A vaccine that targets amyloid beta in the brain to treat Alzheimer's disease has been granted fast-track designation by the FDA.

STORY AT-A-GLANCE

• The U.S. Food and Drug Administration granted fast-track designation to UB-311, a vaccine for Alzheimer’s disease made by biotechnology company Vaxxinity

• Aside from the potential problems that can arise when a vaccine is rushed to market, the vaccine may be problematic from the get-go because amyloid beta may be a symptom of Alzheimer’s,…